Zinger Key Points
- Affirm reported 2025 fiscal-year second-quarter earnings after the market closed on Thursday.
- The company reported earnings per share of 23 cents, beating analysts' estimate of a loss of 16 cents per share.
Affirm Holdings, Inc. AFRM shares are trading higher on Friday after the company reported better-than-expected 2025 fiscal-year second-quarter earnings and strong guidance for the 2025 fiscal-year.
What To Know: Affirm reported earnings per share of 23 cents, beating analysts’ estimate of a loss of 16 cents per share. In addition, the company reported sales of $866.38 million, beating analysts’ estimate of $807.16 million and representing a 47% year-over-year increase.
Affirm attributed its revenue growth to several factors, including a 42% increase in interest income driven by a rise in loans held for investment. Additionally, the company reported a 33% increase in network revenue and a 138% growth in gain on loan sales.
Furthermore, the company reported gross merchandise volume of $10.1 billion, a 35% year-over-increase. Affirm reported direct-to-consumer gross merchandise volume of $2.8 billion.
In its letter to shareholders, the company stated, "Affirm is in the strongest shape it’s ever been. Challenges met, competitors bested: excellent growth in a rapidly expanding segment, on-target unit economics, robust operating leverage.”
The company also issued guidance for the 2025 fiscal-year. It sees revenue from $3.13 billion to $3.19 billion, versus analysts’ estimate of $3.09 billion.
Analyst Changes: Following the earnings report, several analysts issued price target adjustments.
- Needham analyst Kyle Peterson reiterated a Hold rating on Affirm.
- Wells Fargo analyst Andrew Bauch maintained an Overweight rating on Affirm Holdings and raised the price target from $70 to $85.
See Also: Top 2 Tech Stocks That May Collapse In February
AFRM Price Action: At the time of writing, Affirm shares are trading 19.0% higher at $73.48, according to data from Benzinga Pro.
Image: Courtesy of Affirm
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.